DENTALINDUSTRY BRIEF

Issue 1 · Nov 17, 2026

Henry Schein's U.S. dental merchandise sales jump 8.6%

ISSUE 1 · NOV 17, 2026
Henry Schein's U.S. dental merchandise sales jump 8.6%
DENTAL INDUSTRY BRIEF

Schein credits share gains in a stable market, Dentsply Sirona's sales fall 7.6%, and a Straumann abutment recall reaches 25 states.

The Big Picture: Third quarter earnings split the dental supply chain. Henry Schein grew U.S. dental merchandise 8.6% by taking share. Dentsply Sirona's sales fell 7.6%. Both booked one-time IEEPA tariff refunds. Add a Straumann abutment recall and a DSO closing its biggest deal yet.

The Big Story: Henry Schein says it is taking share in U.S. dental

Henry Schein reported third quarter results on Nov 3. Total sales were $3.5 billion, up 4.0%. U.S. dental merchandise sales rose 8.6%, mainly on volume from market share gains, in what CEO Fred Lowery called "a stable market." U.S. dental equipment grew 1.6%.

Non-GAAP diluted EPS was $1.56, up 13.0%, including a $0.19 per share benefit from IEEPA tariff refunds. Schein raised full year non-GAAP EPS guidance to $5.50 to $5.56, from $5.29 to $5.39, and kept its 4.5% to 5.5% sales growth outlook.

Who it affects: Distributor reps at Benco, Patterson and the regionals, and manufacturer reps whose sundries ride on Schein's trucks.

Why it matters: In a stable market, 8.6% merchandise growth comes out of someone else's accounts. Expect sharper consumables pricing in the fourth quarter, and know which distributor each key account favors before year end budgets lock.

Sources: Henry Schein Q3 2026 release (SEC), Becker's Dental Review

New here? Get this in your inbox.

A free five minute brief every Tuesday morning, written for the people who sell into this industry.

Get it free every Tuesday

Straumann recalls healing abutments over sterility risk

FDA posted a Class 2 recall on Nov 9 for six article numbers of Straumann Healing Abutments, Ti, citing potential contamination that could compromise sterility. Only 23 units are in commerce, but they went to 25 states.

Straumann began calling customers on Sept 30. Practices should quarantine affected units and return them for replacement. Abutments already placed do not need to come out.

Why it matters: Straumann reps should confirm every affected customer returned its confirmation form. Competing implant reps will hear about it in the operatory, so know the facts first.

Sources: FDA recall Z-0398-2027

Earnings Watch

  • Dentsply Sirona (Nov 5): Sales of $836 million, down 7.6%. Connected Technology Solutions fell 11.0% and Essential Dental Solutions 4.0%. Adjusted EPS of $0.29 includes a one-time $39 million inventory benefit. Full year outlook: about $3.5 billion in sales and adjusted EPS of $1.20 to $1.30.
  • Envista (Nov 4): Sales of $691.5 million with 2.7% core growth. Envista raised its adjusted EPS outlook to $1.54 to $1.58.

Two makers, two directions: Envista is still growing, while Dentsply is shrinking in every dental segment.

Sources: Dentsply Sirona Q3 2026 release (SEC), Envista Q3 2026 release

Deal Watch

Park Dental Partners closes its North Carolina deal. The Minnesota DSO closed its purchase of Village Family Dental's DSO on Nov 6, adding 12 locations and 47 doctors in its fourth state. The practices keep their name and local leadership. Park Dental Partners release

People Moves

Parkview Dental Partners: The Sarasota, Fla. DSO named Jon Gregoire CEO on Nov 3. He was COO of P1 Dental Partners for five years. Parkview release

Know of a move we should cover? Tell us here.

THE NUMBER
16.6%

How far Dentsply Sirona's Orthodontic and Implant Solutions sales fell in the third quarter, its weakest segment. Source

Talk Track

Three questions to ask your practices and DSO buyers this week:

  1. Has your main distributor changed its pricing or its rep coverage since the summer?
  2. Are you buying more consumables from one supplier now than you were a year ago, and why?
  3. For implant cases: did you get the Straumann recall letter, and do you have replacement parts on hand?

The rep who knows where the share is moving gets the next order.

Jobs

  • Our picks this week, all checked live on Nov 16.
  • Territory Sales Representative, Endodontics, Dentsply Sirona (Newark, N.J. area, home office). $70,000 to $125,000 base plus incentive. Posted Nov 12. Apply
  • Territory Sales Representative, Dental Implants, Dentsply Sirona (Riverside or Palm Springs, Calif., home office). Calls on oral surgery practices. $70,000 to $150,000 base and variable. Posted Nov 11. Apply
  • Territory Sales Representative, Implants MIS, Dentsply Sirona (Denver area, home office). A new business role. $75,000 to $150,000 or more, base and variable. Posted Nov 7. Apply

What We're Watching

  • Tariff refunds: Schein's guidance assumes no significant further refunds in 2026. Watch fourth quarter results.
  • Align Technology's buyback: Align signed a $270 million accelerated share repurchase on Nov 6, which it says brings its 2026 buybacks to about $500 million. Align release (SEC)

We're looking for industry advisors and contributors

We want distributor and manufacturer reps, DSO purchasing teams and practice administrators who can tell us what they see in the field.

Advisors send tips, read a story before we publish, or write a short piece. You get credit by name in the brief, nothing else.

Raise your hand here, with a line about your role.

Forward this to someone on your team who'd use it.

The Editorial Team

Reading this on the web?

A free five minute brief every Tuesday morning, written for the people who sell into this industry.

Get it free every Tuesday

Dental Industry Brief is an independent publication by its editorial team. Nothing here is investment advice.